Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Adamis Pharmaceuticl (ADMP)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Latest Headlines for [[ item.sessionDateDisplayLong ]]
Pharma Stock Roundup: NVS to Divest Eye Care Unit, CHMP Gives Nod to Several Drugs

Novartis (NVS) intends to spin off its Alcon eye care division. The CHMP gives positive opinion recommending marketing approval to several drugs.

AZN : 37.17 (+0.38%)
JNJ : 125.85 (-0.07%)
MRK : 62.52 (+0.02%)
ADMP : 3.80 (+4.11%)
NVS : 82.27 (+1.82%)
GSK : 41.87 (+2.90%)
BMY : 56.71 (+0.30%)
Adamis (ADMP) Surges Following Novartis Deal for Symjepi

Shares of Adamis (ADMP) skyrocket after the company signs a commercialization deal with Novartis for Symjepi.

MYL : 35.53 (-0.31%)
AGN : 171.79 (-0.92%)
ADMP : 3.80 (+4.11%)
NVS : 82.27 (+1.82%)
Today's Research Reports on Stocks to Watch: Adamis Pharmaceuticals and MiMedx

NEW YORK, NY / ACCESSWIRE / July 3, 2018 / Adamis Pharmaceuticals shares exploded on Monday after announcing that it has found a commercial partner for its allergic reaction treatment Symjepi. Shares...

MDXG : 3.74 (-6.97%)
ADMP : 3.80 (+4.11%)
Adamis Pharmaceuticals Announces Distribution and Commercialization Agreement for Symjepi

Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) ("Adamis") announced today that it has entered into an exclusive distribution and commercialization agreement with Sandoz Inc. ("Sandoz"), a division of...

ADMP : 3.80 (+4.11%)
Complimentary Technical Snapshots on Valeant Pharmaceuticals International and Three More Healthcare Stocks

Stock Research Monitor: QTNT, ADMP, and PETS

PETS : 40.19 (-2.85%)
ADMP : 3.80 (+4.11%)
QTNT : 7.71 (-0.26%)
Implied Volatility Surging for Adamis Pharmaceuticals (ADMP) Stock Options

Adamis Pharmaceuticals (ADMP) needs investors to pay close attention to the stock based on moves in the options market lately.

ADMP : 3.80 (+4.11%)
Options Traders Expect Huge Moves in Adamis Pharmaceuticals (ADMP) Stock

Adamis Pharmaceuticals (ADMP) needs investors to pay close attention to the stock based on moves in the options market lately.

ADMP : 3.80 (+4.11%)
Implied Volatility Surging for Adamis Pharmaceuticals (ADMP) Stock Options

Investors in Adamis Pharmaceuticals (ADMP) need to pay close attention to the stock based on moves in the options market lately.

ADMP : 3.80 (+4.11%)
Recent Analysis Shows J.Jill, BankUnited, Toronto Dominion Bank, Adamis Pharmaceuticals, BioDelivery Sciences International, and First Solar Market Influences -- Renewed Outlook, Key Drivers of Growth

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of J.Jill, Inc. (NYSE:JILL), BankUnited,...

TD : 57.91 (+0.68%)
FSLR : 53.48 (-0.74%)
BDSI : 2.80 (-2.61%)
ADMP : 3.80 (+4.11%)
JILL : 8.69 (-3.77%)
BKU : 40.01 (+0.20%)
What Falling Estimates & Price Mean for Adamis Pharmaceuticals (ADMP)

Adamis Pharmaceuticals (ADMP) has witnessed a significant price decline in the past four weeks, and it has seen negative earnings estimate revisions as well.

ADMP : 3.80 (+4.11%)
BSTC : 46.70 (-0.51%)
Free Research Reports on These Drug Delivery Stocks -- Alkermes, PetMed Express, Valeant Pharma, and Adamis Pharma

WallStEquities.com strives to bring the best free research to the investment community. Today we are offering reports on ALKS, PETS, VRX, and ADMP which can be accessed for free by signing up to www.wallstequities.com/registration....

VRX.TO : 30.80 (-3.33%)
PETS : 40.19 (-2.85%)
ADMP : 3.80 (+4.11%)
ALKS : 45.04 (-0.53%)
VRX : 23.40 (-3.43%)
Adamis Pharmaceuticals Provides Update on Data Presented at the American Academy of Allergy, Asthma and Immunology (AAAAI) Joint Congress With the World Allergy Organization

Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) ("Adamis") today provided an update on data from its presentation entitled "Human Factors Study of A Newly Approved Epinephrine Prefilled Syringe (Symjepi)...

ADMP : 3.80 (+4.11%)
Adamis Pharmaceuticals Updates Symjepi Commercialization Plans

Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) today provided an update on the progress of exploring commercialization options relating to the commercial launch of its Symjepi (epinephrine) Injection...

ADMP : 3.80 (+4.11%)
Quotidian Technical Highlights on Selected Healthcare Stocks -- Atossa Genetics, Palatin Technologies, Adamis Pharma, and Perrigo

WallStEquities.com strives to bring the best free research to the investment community. Today we are offering reports on ATOS, PTN, ADMP, and PRGO which can be accessed for free by signing up to www.wallstequities.com/registration....

ADMP : 3.80 (+4.11%)
ATOS : 2.49 (unch)
PTN : 1.01 (+1.00%)
PRGO : 75.97 (+0.18%)
Adamis Pharmaceuticals Announces FDA Acceptance for Review for the Supplemental New Drug Application of Its Low Dose Symjepi Product Candidate

Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) ("Company" or "Adamis") today announced that the U.S. Food and Drug Administration ("FDA") has accepted for review the Company's supplemental New Drug Application...

ADMP : 3.80 (+4.11%)
Report: Exploring Fundamental Drivers Behind Vector Group, NovoCure, ORBCOMM, Adamis Pharmaceuticals, Calumet Specialty Products Partners, and Lakeland -- New Horizons, Emerging Trends, and Upcoming Developments

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Vector Group Ltd. (NYSE:VGR),...

VGR : 18.57 (+0.76%)
ORBC : 10.12 (+0.10%)
NVCR : 37.55 (+0.67%)
ADMP : 3.80 (+4.11%)
LBAI : 20.55 (+0.74%)
CLMT : 7.75 (-1.27%)
Stock Performance Review on Drug Delivery Industry -- Adamis Pharma, Alkermes, PetMed Express, and Valeant Pharma

If you want a Stock Review on ADMP, ALKS, PETS, or VRX then come over to http://dailystocktracker.com/register/ and sign up for your free customized report. On Wednesday, the NASDAQ Composite ended the...

PETS : 40.19 (-2.85%)
ADMP : 3.80 (+4.11%)
ALKS : 45.04 (-0.53%)
VRX : 23.40 (-3.43%)
Technical Snapshots for these Drug Delivery Stocks -- Delcath Systems, Valeant Pharma, PetMed Express, and Adamis Pharma

If you want a Stock Review on DCTH, VRX, PETS, or ADMP then come over to http://dailystocktracker.com/register/ and sign up for your free customized report today. The market for Drug Delivery technology...

VRX.TO : 30.80 (-3.33%)
PETS : 40.19 (-2.85%)
ADMP : 3.80 (+4.11%)
DCTH : 2.5500 (+4.08%)
VRX : 23.40 (-3.43%)
Why Have Mylan's (MYL) Shares Lost 19.4% So Far This Year?

Shares of Mylan N.V. (MYL) have lost almost 19.4% in the year so far given the competitive pressure.

MYL : 35.53 (-0.31%)
ADMP : 3.80 (+4.11%)
NVS : 82.27 (+1.82%)
GSK : 41.87 (+2.90%)
Today's Research Reports on Stocks to Watch: Adamis Pharmaceuticals and Mylan

NEW YORK, NY / ACCESSWIRE / August 14, 2017 / While shares of Mylan continued to suffer last Friday, competitor Adamis Pharmaceuticals saw gains. Adamis has an Epinephrine injection that is a generic...

MYL : 35.53 (-0.31%)
ADMP : 3.80 (+4.11%)

Van Meerten Stock Picks

5 Terrific Mid Caps
In this roller coaster market I wanted to find Mid Cap stocks that had consistent price appreciation over the last 6 month period.
EHC -0.38 , FTNT +0.53 , CAKE -0.45 , PLT -0.28 , AEO -0.65
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.
Free Commodities Newsletter

Get prepared for your trading day with

Barchart's Commodity Futures Morning Update Email

InsideFutures Commentary

InsideFutures weekly newsletter features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Friday morning to your inbox.

Agricharts Market Commentary

Today's Commentary

Corn futures closed the week with most contracts 3 to 4 cents higher on Friday. Nearby September was up 4.1% since last Friday, with higher closes every day this week. Solid exports and drier weather fueled some bottom picking and short covering acti...
Read More

Alan Brugler writes this daily agricultural markets overview with opening, midday and closing comments directed at the gain and meat Ag markets.

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.

Free Barchart Webinar